Cargando…

Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study

BACKGROUND: Whether the suggested inverse association between total cholesterol and mortality in old age varies according to cause of death and use of cholesterol medications remains to be elucidated. The aim of this study was to assess the associations of total cholesterol with cardiovascular and n...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Yajun, Vetrano, Davide Liborio, Qiu, Chengxuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745647/
https://www.ncbi.nlm.nih.gov/pubmed/29281976
http://dx.doi.org/10.1186/s12877-017-0685-z
_version_ 1783288943817523200
author Liang, Yajun
Vetrano, Davide Liborio
Qiu, Chengxuan
author_facet Liang, Yajun
Vetrano, Davide Liborio
Qiu, Chengxuan
author_sort Liang, Yajun
collection PubMed
description BACKGROUND: Whether the suggested inverse association between total cholesterol and mortality in old age varies according to cause of death and use of cholesterol medications remains to be elucidated. The aim of this study was to assess the associations of total cholesterol with cardiovascular and non-cardiovascular mortality in old age, and to explore whether their associations vary by use of cholesterol-lowering medications. METHODS: The study participants included 3090 older adults (age ≥ 60 years, 63.7% women) from a population-based cohort study, i.e., the Swedish National study on Aging and Care in Kungsholmen, Stockholm. At baseline (2001–2004), data on demographic factors, lifestyles, cardiovascular risk factors, use of medications, global cognitive function, mobility limitation, and apolipoprotein E genotype were collected through interviews, clinical examinations, laboratory tests as well as from the Swedish national patient register. Vital statistics data (e.g., date and causes of death) till December 31, 2011 for all participants were derived from Swedish cause of death register. Data were analyzed using Cox proportional hazards model for all-cause mortality and Fine-Gray competing risks regression model for cause-specific mortality controlling for multiple potential confounders. RESULTS: During 23,196 person-years of follow-up (median per person, 7.5 years), 1059 (34.3%) participants died. Compared to normal total cholesterol (<5.18 mmol/l), borderline-high (5.18–6.21 mmol/l) and high (≥6.22 mmol/l) total cholesterol were associated with a decreased risk of all-cause mortality, with the multiple-adjusted hazard ratio (95% confidence interval, CI) of 0.71 (0.61–0.83) and 0.68 (0.57–0.80), respectively (P for trend <0.001). The competing risk regression models revealed that the reduced all-cause mortality associated with high total cholesterol (≥6.22 mmol/l)) was mainly due to the reduced risk of non-cardiovascular mortality (hazard ratio = 0.67, 95% CI = 0.51–0.88). These associations were statistically evident only among individuals without use of cholesterol-lowering medications. CONCLUSIONS: The inverse association between high total cholesterol and reduced all-cause mortality in older adults is primarily due to non-cardiovascular mortality, especially among those who are not treated with cholesterol-lowering medications.
format Online
Article
Text
id pubmed-5745647
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57456472018-01-03 Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study Liang, Yajun Vetrano, Davide Liborio Qiu, Chengxuan BMC Geriatr Research Article BACKGROUND: Whether the suggested inverse association between total cholesterol and mortality in old age varies according to cause of death and use of cholesterol medications remains to be elucidated. The aim of this study was to assess the associations of total cholesterol with cardiovascular and non-cardiovascular mortality in old age, and to explore whether their associations vary by use of cholesterol-lowering medications. METHODS: The study participants included 3090 older adults (age ≥ 60 years, 63.7% women) from a population-based cohort study, i.e., the Swedish National study on Aging and Care in Kungsholmen, Stockholm. At baseline (2001–2004), data on demographic factors, lifestyles, cardiovascular risk factors, use of medications, global cognitive function, mobility limitation, and apolipoprotein E genotype were collected through interviews, clinical examinations, laboratory tests as well as from the Swedish national patient register. Vital statistics data (e.g., date and causes of death) till December 31, 2011 for all participants were derived from Swedish cause of death register. Data were analyzed using Cox proportional hazards model for all-cause mortality and Fine-Gray competing risks regression model for cause-specific mortality controlling for multiple potential confounders. RESULTS: During 23,196 person-years of follow-up (median per person, 7.5 years), 1059 (34.3%) participants died. Compared to normal total cholesterol (<5.18 mmol/l), borderline-high (5.18–6.21 mmol/l) and high (≥6.22 mmol/l) total cholesterol were associated with a decreased risk of all-cause mortality, with the multiple-adjusted hazard ratio (95% confidence interval, CI) of 0.71 (0.61–0.83) and 0.68 (0.57–0.80), respectively (P for trend <0.001). The competing risk regression models revealed that the reduced all-cause mortality associated with high total cholesterol (≥6.22 mmol/l)) was mainly due to the reduced risk of non-cardiovascular mortality (hazard ratio = 0.67, 95% CI = 0.51–0.88). These associations were statistically evident only among individuals without use of cholesterol-lowering medications. CONCLUSIONS: The inverse association between high total cholesterol and reduced all-cause mortality in older adults is primarily due to non-cardiovascular mortality, especially among those who are not treated with cholesterol-lowering medications. BioMed Central 2017-12-28 /pmc/articles/PMC5745647/ /pubmed/29281976 http://dx.doi.org/10.1186/s12877-017-0685-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Liang, Yajun
Vetrano, Davide Liborio
Qiu, Chengxuan
Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study
title Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study
title_full Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study
title_fullStr Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study
title_full_unstemmed Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study
title_short Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study
title_sort serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745647/
https://www.ncbi.nlm.nih.gov/pubmed/29281976
http://dx.doi.org/10.1186/s12877-017-0685-z
work_keys_str_mv AT liangyajun serumtotalcholesterolandriskofcardiovascularandnoncardiovascularmortalityinoldageapopulationbasedstudy
AT vetranodavideliborio serumtotalcholesterolandriskofcardiovascularandnoncardiovascularmortalityinoldageapopulationbasedstudy
AT qiuchengxuan serumtotalcholesterolandriskofcardiovascularandnoncardiovascularmortalityinoldageapopulationbasedstudy